Conclusions
Currently, there are no standard guidelines for the timing of PPMI following TAVR. The reviewed literature suggests a liberal use of PPMI immediately after TAVR, since a temporary pacemaker and more extended rhythm monitoring of all patients post-procedure can increase hospitalization days and costs and delay rehabilitation (49). Novel technology like Tempo pacemaker can be used safely for temporary pacing in ambulating patients for up to 7 days post TAVR, and needs further validation (51). Our meta-analysis identified 14 factors significantly associated with increased risk of PPMI following TAVR. This suggests that recognizing the high-risk population prior to performing TAVR, and targeting the risk factors that are modifiable, can help reduce the rate of PPMI.